Changes in Stockholders' Deficit (Detail) - USD ($) $ in Thousands		3 Months Ended		8 Months Ended
		Sep. 06, 2015	Sep. 07, 2014	Sep. 06, 2015	Sep. 07, 2014
Stockholders' Deficit [Line Items]
Beginning Balance	[1]			$ (1,219,465)
Net income		$ 37,832	$ 35,618	130,030	$ 114,554
Tax payments for restricted stock upon vesting				(7,442)	(7,889)
Non-cash compensation expense		3,412	$ 3,817	11,188	$ 11,897
Ending Balance		$ (1,255,949)		$ (1,255,949)
Common Stock [Member]
Stockholders' Deficit [Line Items]
Beginning Balance, (in shares)				55,553,149
Beginning Balance				$ 556
Issuance of common stock, net, (in shares)				79,375
Issuance of common stock, net				$ 1
Tax payments for restricted stock upon vesting, (in shares)				(69,334)
Tax payments for restricted stock upon vesting				$ (1)
Purchases of common stock, (in shares)				(1,293,924)
Purchases of common stock				$ (13)
Exercise of stock options, (in shares)				377,677
Exercise of stock options				$ 3
Ending Balance, (in shares)		54,646,943		54,646,943
Ending Balance		$ 546		$ 546
Additional Paid-in Capital [Member]
Stockholders' Deficit [Line Items]
Beginning Balance				29,561
Tax payments for restricted stock upon vesting				(7,441)
Purchases of common stock				(52,236)
Exercise of stock options				4,456
Tax impact from equity-based compensation				15,745
Non-cash compensation expense				11,188
Ending Balance		1,273		1,273
Retained Deficit [Member]
Stockholders' Deficit [Line Items]
Beginning Balance				(1,246,921)
Net income				130,030
Common stock dividends				(51,095)
Purchases of common stock				(86,301)
Ending Balance		(1,254,287)		(1,254,287)
Accumulated Other Comprehensive Loss [Member]
Stockholders' Deficit [Line Items]
Beginning Balance				(2,661)
Currency translation adjustment, net of tax				(820)
Ending Balance		$ (3,481)		$ (3,481)

[1] The balance sheet at December 28, 2014 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.